World Bioinformatics Market

Home >
Life Sciences >
Biotechnology >
World Bioinformatics Market

Report price : $ 4 450
Publication date : May 2008
Length : 709 pages

This report analyzes the worldwide markets for Bioinformatics in Millions of US$. The major product segments analyzed are Software, Hardware, and Biocontent. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 228 companies including many key and niche players worldwide such as 3rd Millennium, Inc., Accelrys, Inc., Affymetrix, Agilent Technologies, Applied Biosystems, BioWisdom Ltd., Celera Group, Gene Logic, Geneva Bioinformatics S.A., IBM Life Sciences, InforSense Ltd., InPharmix Incorporated, Invitrogen Corp., Kinexus Bioinformatics Corporation, Nonlinear Dynamics Ltd., and Rosetta Inpharmatics. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

BIOINFORMATICS MCP-1095
A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Software I-3
Hardware I-3
Biocontent I-3

II. EXECUTIVE SUMMARY

1. Industry Overview II-1
Revolution in Biology II-1
Outlook II-1
Analysis by Product Segment II-1
Software II-1
Biocontent II-1
Hardware II-1
Industry Structure II-2
Industry Challenges II-2
Consolidation- A Key to Success II-2

2. Introduction to Bioinformatics II-3
Bioinformatics Assumes More Comprehensive Role II-3
Bioinformatics: Definition II-3
Bioinformatics: History in Brief II-3
Functions of Bioinformatics II-4
Major End-Users of Bioinformatics II-4
Interface of IT and Biosciences II-4
Venture Capital and Bioinformatics II-5
Branches Associated with Bioinformatics II-5
Emerging Clinical Genomics Industry II-5
Genomic Business Models II-6
Applications of Bioinformatics II-6
Bioinformatics: Crucial for New Drug Development II-6
Application of Bioinformatics to Oral Genomics II-6
Importance of IP Protection Systems in Bioinformatics II-7

3. Insight into Bioinformatics Technology II-8
Protein Structure and its Determination II-8
Components of Bioinformatics II-8
Software II-8
Hardware II-8
Biocontent II-8
Proteins/ Proteomics Data and Databases II-8
DNA Sequences and Protein Sequencing II-9
Aligning Sequences II-9
Databases II-10
Nucleotide Databases II-10
EMBL Nucleotide Sequence Database II-10
DNA Database of Japan (DDBJ) II-11
GenBank II-11
Institute for Genomic Research (TIGR) II-11
Protein Databases II-11
SWISS-PROT II-11
TrEMBL II-11
IMGT/LIGM-DB II-11
PROSITE II-11
Design and Development of XML Bioinformatics Environment II-11
Biopolymer Markup Language (BioML) II-11
Bioinformatics Sequence Mark-Up Language - BSML II-11
Genome Annotation Markup Elements (GAME) II-11
Microarray Markup Language (MAML) II-11
Gene Expression Markup Language (GEML™) II-12
Hardware II-12
Technologies Involved II-12
Computer-Assisted Imaging, Mapping and High-Throughput
Screening II-12
Database Engineering II-12
Computer Processing II-12
Computational Software II-12

4. Product Innovations/Introductions II-13
Accelrys Rolls Out Three New Component Collections for its
SciTegic Pipeline Pilot™ II-13
Agilent Technologies Unveils Gene Expression Bioinformatics
System, GeneSpring GX 9.0 II-13
GeneBio and SIB Roll Out New Version of Melanie 2-D Gel
Analysis Platform II-13
InforSense to Incorporate BioWisdom’s SRS software in its
Workflow Analytics Platform II-13
BioWisdom Launches SRS 3D Technology, as a Free Software II-14
GeneGo Integrates Cytoscape Software on its Data Analysis
Platform II-14
Applied Biosystems and Integromics Unveil Integrated Real-
Time PCR Data Analysis Solution II-14
Applied Biosystems Rolls Out Advanced DNA Sequencing
Platform, The SOLiD™ System II-14
GeneBio Introduces New Version of Phenyx Platform II-15
TCS to Introduce Enhanced Bioinformatics Software, BioAppliance II-15
Applied Biosystems Introduces Genotyping Service Provider
Program II-15
Applied Biosystems Launches Variant Reporter™, Genetic
Variation Data Analysis Software II-15
GeneBio Launches Online Platform of Phenyx, PhenyxOnline. II-15
InforSense Rolls Out a Statistical Genetics Solution, GenSense II-16
U. S. Department of Energy Joint Genome Institute Introduces
IMG Version 2.1 II-16
CLC bio Launches CLC Bioinformatics Cell II-16
Accelrys Unveils Imaging Software for SciTegic Pipeline Pilot II-16
CLC bio Launches the Pioneering Customizable Bioinformatics Suite II-17
Jalaja Technologies and The Institute of Genomics &
Integrative Biology Devise GENO-CLUSTER Bioinformatics
Software II-17
CLC Bio Launches Four New Bioinformatics Software II-18
Insightful Develops Bioinformatics Software for National
Cancer Institute II-18
3rd Millennium Unveils 2.0 ARDAS™ Software II-18
GeneBio Introduces Phenyx 2.1 for Proteomics MS Data Analysis II-18
BioWisdom Unveils SRS 8.2 II-19
INCOGEN Releases Version 3.3 of VIBE Data Pipelining Software
for Bioinformatics II-19
INCOGEN Introduces VIBE 3.1 Bioinformatics Data Pipelining
Software II-19
InforSense Launches InforSense KDE, InforSense BioSense Grid
on Mac OS X V 10.4 II-19
Massively Parallel Technologies Completes Early Beta Testing
of Bioinformatics Tool II-19
Kinexus Announces Launch of KiNET Functional Proteomics Database II-20
Agilent Technologies Launches Search Tool for Cytoscape
Bioinformatics Platform II-20
Ocimum Develops DNA Analysis Software II-20
Apple Computer Launches Bioinformatics Cluster II-20
EBI, Swiss Institute of Bioinformatics and Georgetown
University Launch UniProt II-20

5. Recent Industry Activity II-21
InforSense and Crosslinks Ink Research Alliance II-21
Chemizon and KRIBB Team Up to establish a New Biotech Company II-21
BIOBASE Establishes a New Japanese Subsidiary, Nihon BIOBASE KK II-21
Applied Biosystems Ropes in Geospiza® and GenomeQuest into
Software Development Community for Developing Advanced
Bioinformatics Tools II-21
InforSense and BioWisdom Enter Bioinformatics Agreement II-22
Gene Logic Completes Sale of its Genomic assets to Ocimum
Biosolutions II-22
SGI Develops World's Largest FPGA Supercomputer II-22
Progeniq Enrolls into BioIT Alliance II-22
Applied Biosystems Launches Software Development Community for
Advancing Bioinformatics Applications for its SOLiD™ System II-22
Agilent and Strand Life Sciences Ink Software Development
Agreement II-23
Cell Therapeutics to Acquire Systems Medicine II-23
SGI Enrolls into Bio-IT Alliance II-23
GenoLogic Joins Illumina’s Bioinformatics Program, Illumina
Connect II-23
InApp Software to Establish a Bioinformatics Society in India II-23
Agilent Technologies Partners with Gene Logic for Research
and iscovery Projects II-24
Thomson, Corp. Acquires Unleashed Informatics II-24
iHorizons Signs R&D Agreement With AREA Science Park and
Cluster in Biomedicine II-24
GeneBio’s Software to be Integrated into Biozentrum’s
Proteomics Cluster II-25
BioWisdom Signs Agreement with the European Bioinformatics
Institute to Deliver SRS 8.2 II-25
Genencor Licenses ERGO™ Software to Integrated Genomics II-25
Intelligent Business Systems Signs MOU to Establish a
Biotechnology Solutions Venture in India II-25
Nonlinear Dynamics and Agilent Sign Co-Marketing Deal II-26
Agilent Technologies’ Bioinformatics Solution Enables
Platforms’ Standardization at NCI II-26
LION Bioscience Divests Bioinformatics Business to BioWisdom II-27
Applied Biosystems Collaborates with GeneGo II-27
BioWisdom and AstraZeneca Extend Partnership for Intelligence
Networks II-27
BioWisdom Extends SRS Licenses for Boehringer Ingelheim II-28
Sheba and Weizmann Attain Licenses for Partek’s Genomics Suite
Software II-28
Sirna Gains Exclusive Worldwide License for miRNA Technology II-28
HSARPA to Commence Bioinformatics and Assay Development Programme II-28
Syngenta Selects InforSense® to Develop Bioinformatics
Computational Platform II-28
Stratagene Partners with Strand Life Sciences for Advanced
Bioinformatics Software Tools II-28
Nonlinear Dynamics Join Forces with Genedata Over Proteomics
Research II-29
RTI International Bags Bioinformatics Contracts from the
National Institutes of Health's NCI II-29
Cold Spring Harbor Lab Kicks off Bioinformatics Expansion II-29
Iowa State Bags $3 Million IGERT Grant for Bioinformatics II-29
AMITY, MASCON Announce Partnership for Bioinformatics R&D II-29
BioTeam Teams Up InforSense to Develop Grid Computing
Environment for Bioinformatics II-30
Nonlinear and Water Corp Ink Agreement II-30
Clarient Signs Bioinformatics Patent Licensing Agreement With HDC II-30
Gene-IT to Develop Bioinformatics Technology II-30
AstraZeneca Purchases License for Target Informatics Platform
from Eidogen-Sertanty II-30
SRI International Expands BioCyc Database Collection II-31
JBRIC Selects United Device’s Grid MP II-31
India’s TCS Introduces Bioinformatics Software II-31
Japan’s Hitachi and the University of Tokyo Establish New Venture II-31
Sun Microsystems Launches Bioinformatics Cluster II-31
Sun Micro Establishes Medical Bioinformatics Center in India II-31
Expression Analysis forms Alliance with InPharmix II-32
W&G Offers Gene-Typing Service II-32
Health Discovery Acquires Fractal Genomics II-32
Celera Diagnostics Collaborates with Merck II-32
IBM and NIE Launch NBL II-32
Proteome Systems and CSIRO Team Up II-32
Ocimum Signs Life Sciences Deal II-32
Beckman Boosts up its Systems Biology Technologies II-33

6. Focus on Select Players II-34
3rd Millennium, Inc (US) II-34
Accelrys, Inc. (US) II-34
Affymetrix (US) II-34
Agilent Technologies (US) II-35
Applied Biosystems (US) II-35
BioWisdom Ltd (UK) II-35
Celera Group (US) II-36
Gene Logic (US) II-36
Geneva Bioinformatics S.A (Switzerland) II-36
IBM Life Sciences (US) II-36
InforSense Ltd (UK) II-37
InPharmix Incorporated (US) II-37
Invitrogen Corp.(US) II-37
Kinexus Bioinformatics Corporation (Canada) II-38
Nonlinear Dynamics Ltd (UK) II-38
Rosetta Inpharmatics (US) II-38

7. Global Market Perspective II-40
Table 1: World Recent Past, Current & Future Market Analysis
for Bioinformatics by Geographic Region - the US, Canada,
Japan, Europe, Asia-Pacific and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) II-40

Table 2: World Long-term Projections for Bioinformatics by
Geographic Region - the US, Canada, Japan, Europe,
Asia-Pacific and Rest of World Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2011
through 2015 (includes corresponding Graph/Chart) II-41

Table 3: World 10-Year Perspective for Bioinformatics
by Geographic Region - Percentage Breakdown of Dollar
Sales for the US, Canada, Japan, Europe, Asia-Pacific
and Rest of World for Years 2003, 2008 & 2012
(includes corresponding Graph/Chart) II-42
Analytics by Product Segment II-43
Table 4: World Recent Past, Current & Future Market Analysis
for Software (Bioinformatics) by Geographic Region - the US,
Canada, Japan, Europe, Asia-Pacific andRest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) II-43

Table 5: World Long-term Projections for Software
(Bioinformatics) by Geographic Region - the US, Canada, Japan,
Europe, Asia-Pacific and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) II-44

Table 6: World 10-Year Perspective for Software
(Bioinformatics) by Geographic Region - Percentage Breakdown
of Dollar Sales for the US, Canada, Japan, Europe,
Asia-Pacific and Rest of World for Years 2003, 2008 & 2012
(includes corresponding Graph/Chart) II-45

Table 7: World Recent Past, Current & Future Market Analysis
for Biocontent (Bioinformatics) by Geographic Region - the US,
Canada, Japan, Europe, Asia-Pacific and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000through 2010 (includes corresponding
Graph/Chart) II-46

Table 8: World Long-term Projections for Biocontent
(Bioinformatics) by Geographic Region - the US, Canada, Japan,
Europe, Asia-Pacific and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) II-47

Table 9: World 10-Year Perspective for Biocontent
(Bioinformatics) by Geographic Region - Percentage Breakdown
of Dollar Sales for the US, Canada, Japan, Europe,
Asia-Pacific and Rest of World for Years 2003, 2008 & 2012
(includes corresponding Graph/Chart) II-48

Table 10: World Recent Past, Current & Future Market Analysis
for Hardware (Bioinformatics) by Geographic Region - the US,
Canada, Japan, Europe, Asia-Pacific and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) II-49

Table 11: World Long-term Projections for Hardware
(Bioinformatics) by Geographic Region - the US, Canada, Japan,
Europe, Asia-Pacific and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015(includes corresponding Graph/Chart) II-50

Table 12: World 10-Year Perspective for Hardware
(Bioinformatics) by Geographic Region - Percentage Breakdown
of Dollar Sales for the US, Canada, Japan, Europe,
Asia-Pacific and Rest of World for Years 2003, 2008 & 2012
(includes corresponding Graph/Chart) II-51

III. MARKET

1. The United States III-1
A.Market Analysis III-1
Outlook III-1
Market Overview III-1
Patents in Bioinformatics III-1
Product Launches III-2
Strategic Corporate Developments III-6
Focus on Select Players III-13
B.Market Analytics III-17
Table 13: US Recent Past, Current & Future Market Analysis
for Bioinformatics by Product Segment - Software, Biocontent
and Hardware Markets IndependentlyAnalyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-17

Table 14: US Long-term Projections for Bioinformatics by
Product Segment - Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-17

Table 15: US 10-Year Perspective for Bioinformatics by
Product Segment - Percentage Breakdown of Dollar Sales for
Software, Biocontent and Hardware Markets for 2003, 2008 &
2012 (includes corresponding Graph/Chart) III-18

2. Canada III-19
A.Market Analysis III-19
Outlook III-19
Canadian Bioinformatics Industry III-19
Strategic Corporate Developments III-19
Kinexus Bioinformatics Corporation-Key Canadian Player III-19
B.Market Analytics III-20
Table 16: Canadian Recent Past, Current & Future Market
Analysis for Bioinformatics by Product Segment - Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through
2010 (includes corresponding Graph/Chart) III-20

Table 17: Canadian Long-term Projections for Bioinformatics
by Product Segment - Software, Biocontent and Hardware
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2011 through 2015(includes
corresponding Graph/Chart) III-21

Table 18: Canadian 10-Year Perspective for Bioinformatics by
Product Segment Percentage Breakdown of Dollar Sales for
Software Biocontent and Hardware Markets for 2003, 2008 &
2012 (includes corresponding Graph/Chart) III-21

3. Japan III-22
A.Market Analysis III-22
Overview III-22
An Update on Japanese Bioinformatics Industry III-22
JbiC Drives Japanese Bioinformatics Industry III-22
Strategic Corporate Developments III-22
B.Market Analytics III-23
Table 19: Japanese Recent Past, Current & Future Market
Analysis for Bioinformatics by Product Segment - Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through
2010 (includes corresponding Graph/Chart) III-23

Table 20: Japanese Long-term Projections for Bioinformatics
by Product Segment - Software, Biocontent and Hardware
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2011 through 2015(includes
corresponding Graph/Chart) III-24

Table 21: Japanese 10-Year Perspective for Bioinformatics by
Product Segment - Percentage Breakdown of Dollar Sales for
Software, Biocontent and Hardware Markets for 2003, 2008 &
2012 (includes corresponding Graph/Chart) III-24

4. Europe III-25
A.Market Analysis III-25
Outlook III-25
European Bioinformatics Market III-25
Major Public Science Institutes III-25
Regulatory Environment III-25
B.Market Analytics III-26
Table 22: European Recent Past, Current & Future Market
Analysis for Bioinformatics by Geographic Region -France,
Germany, Italy, UK and Rest of Europe Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2010 (includes corresponding Graph/Chart) III-26

Table 23: European Long-term Projections for Bioinformatics
by Geographic Region -France, Germany, Italy, UK and Rest of
Europe Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2011 through 2015(includes
corresponding Graph/Chart) III-27

Table 24: European 10-Year Perspective for Bioinformatics by
Geographic Region - Percentage Breakdown of Dollar Sales for
France, Germany, UK, Italy and Rest of Europe for Years
2003, 2008 & 2012 (includes corresponding Graph/Chart) III-27

Table 25: European Recent Past, Current & Future Market
Analysis for Bioinformatics by Product Segment - Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through
2010 (includes corresponding Graph/Chart) III-28

Table 26: European Long-term Projections for Bioinformatics
by Product Segment - Software, Biocontent and Hardware
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) III-28

Table 27: European 10-Year Perspective for Bioinformatics by
Product Segment - Percentage Breakdown of Dollar Sales for
Software, Biocontent and Hardware Markets for 2003, 2008 &
2012 (includes corresponding Graph/Chart) III-29

4a. France III-30
Market Analysis III-30
Table 28: French Recent Past, Current & Future Market
Analysis for Bioinformatics by Product Segments - Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through
2010 (includes corresponding Graph/Chart) III-30

Table 29: French Long-term Projections for Bioinformatics
by Product Segment - Software, Biocontent and Hardware
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) III-31

Table 30: French 10-Year Perspective for Bioinformatics by
Product Segment - Percentage Breakdown of Dollar Sales for
Software, Biocontent and Hardware Markets for 2003, 2008 &
2012 (includes corresponding Graph/Chart) III-31

4b. Germany III-32
Market Analysis III-32
Table 31: German Recent Past, Current & Future Market
Analysis for Bioinformatics by Product Segments -Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through
2010 (includes corresponding Graph/Chart) III-32

Table 32: German Long-term Projections for Bioinformatics by
Product Segment - Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-33

Table 33: German 10-Year Perspective for Bioinformatics by
Product Segment - Percentage Breakdown of Dollar Sales for
Software, Biocontent and Hardware Markets for 2003, 2008 &
2012 (includes corresponding Graph/Chart) III-33

4c. The United Kingdom III-34
A.Market Analysis III-34
Overview III-34
Research Entities III-34
Product Launches III-34
Strategic Corporate Developments III-35
Key Players III-37
B.Market Analytics III-39
Table 34: UK Recent Past, Current & Future Market Analysis
for Bioinformatics by Product Segment - Software, Biocontent
and Hardware Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2000 through 2010
(includes corresponding Graph/Chart) III-39

Table 35: UK Long-term Projections for Bioinformatics by
Product Segment - Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-39

Table 36: UK 10-Year Perspective for Bioinformatics by
Product Segment - Percentage Breakdown of Dollar Sales for
Software, Biocontent and Hardware Markets for 2003, 2008 &
2012 (includes corresponding Graph/Chart) III-40

4d. Italy III-41
Market Analysis III-41
Strategic Corporate Developments III-41
Table 37: Italian Recent Past, Current & Future Market
Analysis for Bioinformatics by Product Segments - Software,
Biocontent and Hardware Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through
2010 (includes corresponding Graph/Chart) III-42

Table 38: Italian Long-term Projections for Bioinformatics
by Product Segment - Software, Biocontent and Hardware
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) III-42

Table 39: Italian 10-Year Perspective for Bioinformatics by
Product Segment - Percentage Breakdown of Dollar Sales for
Software, Biocontent and Hardware Markets for 2003, 2008 &
2012 (includes corresponding Graph/Chart) III-43

4e. Rest of Europe III-44
A.Market Analysis III-44
Outlook III-44
National Service Center for Bioinformatics in Netherlands III-44
Key Player Review III-44
Product Launches III-44
Strategic Corporate Developments III-46
B.Market Analytics III-47
Table 40: Rest of Europe Market Analysis for Bioinformatics
by Product Segment - Recent Past, Current & Future Market
Analysis for Software, Biocontent and Hardware Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-47

Table 41: Rest of Europe Long-term Projections for
Bioinformatics by Product Segment - Software, Biocontent
and Hardware Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-48

Table 42: Rest of Europe 10-Year Perspective for
Bioinformatics by Product Segment - Percentage Breakdown of
Dollar Sales for Software, Biocontent and Hardware Markets
for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-48

5. Asia-Pacific III-49
A.Market Analysis III-49
Outlook III-49
Bioinformatics in Asia-Pacific III-49
India III-49
Taiwan III-50
Australia III-50
Market Drivers III-50
Market Inhibitors III-51
Singapore III-51
Korea III-51
Product Innovations III-51
Strategic Corporate Developments III-52
B.Market Analytics III-55
Table 43: Asia-Pacific Market Analysis for Bioinformatics by
Product Segment - Recent Past, Current & Future Analysis for
Software, Biocontent and Hardware Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2010 (includes corresponding Graph/Chart) III-55

Table 44: Asia-Pacific Long-term Projections for
Bioinformatics by Product Segment - Software, Biocontent and
Hardware Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2011 through 2015(includes
corresponding Graph/Chart) III-55

Table 45: Asia-Pacific 10-Year Perspective for
Bioinformatics by Product Segment - Percentage Breakdown of
Dollar Sales for Software, Biocontent and Hardware Markets
for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-56

6. Rest of World III-57
A.Market Analysis III-57
Outlook III-57
Strategic Corporate Developments III-57
B.Market Analytics III-58
Table 46: Rest of World Market Analysis for Bioinformatics
by Product Segment - Recent Past, Current & Future Analysis
for Software, Biocontent and Hardware Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2010 (includes corresponding Graph/Chart) III-58

Table 47: Rest of World Long-term Projections for
Bioinformatics by Product Segment - Software, Biocontent and
Hardware Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) III-58

Table 48: Rest of World 10-Year Perspective for
Bioinformatics by Product Segment - Percentage Breakdown of
Dollar Sales for Software, Biocontent and Hardware Markets
for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-59

IV. COMPETITIVE LANDSCAPE

RELATED REPORTS

World Automated and Rapid Microbiological Tests Market

$ 3 950
May 2008
709 pages

This report analyzes the worldwide markets for Automated and Rapid Microbiological Tests in Millions of US$. The Major End-Use Segments Analyzed are Clinical Applications (Automated Identification & Susceptibility Systems, Automated Blood Culture Systems, Automated Tuberculosis Systems, Streptococca ...

Industries : Biotechnology

World Proteomics Market

$ 3 950
May 2008
681 pages

This report analyzes the worldwide markets for Proteomics in Millions of US$. The major Product segments analyzed are Expression Proteomics, Functional Proteomics, and Structural Proteomics.The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Ann ...

Industries : Biotechnology

World Biometrics Market

$ 3 950
May 2008
1473 pages

This report analyzes the worldwide markets for Biometrics in Thousands of US$. The major product segments analyzed are AFIS (Automated Fingerprint Identification System), Non-AFIS/Finger Scan, Hand Geometry, Iris/Retinal Scan, Facial Recognition, Voice Recognition, Signature Verification, and Keyst ...

Industries : Biotechnology

Asia Pacific Biotechnology Market (2008-2012)

$ 1 400
August 2009
120 pages

The biotechnology market in Asia-Pacific region looks very lucrative from investment perspective as it has enjoyed double-digit growth in past few years. The industry is attracting more and more private investments in wake of immense growth opportunities and vast untapped biotech markets. Identifyin ...

Industries : Biotechnology

U.S. and Worldwide Monoclonal Antibody Medicine: Current Status and Future Trends

$ 1 000
July 2008

Antibody drugs were a $24 billion business in 2007. Although most pharmaceuticals are chemically synthesized small molecules, antibodies are large and complex proteins (immunoglobulins) that act as the human body’s own weapons against infections, diseases and abnormal cancer cells. Monoclonal anti ...

Industries : Biotechnology

RNA Interference in the Post-Genomic Era: Markets and Technologies

$ 4 850
February 2008

BCC's goal for this study is to determine the status of current and emerging RNA interference (RNAi) technologies and products and to assess their worldwide growth potential over a 5-year period, from 2008 to 2013. Our particular interest is to characterize and quantify the RNAi market potential fo ...

Industries : Biotechnology

Environmental Markets for Biotechnology

$ 4 850
January 2008

This study intends to provide a comprehensive and detailed analysis of the current and forecasted market through 2013 for environmental biotechnology products and their use in a variety of waste treatment markets. This study contributes information and data that provide a total picture of the indust ...

Industries : Biotechnology

Global Biochip Markets: Microarrays and Lab-on-a-Chip

$ 4 850
September 2007

Biology is following a path that is reminiscent of the early electronics industry: a miniaturization and large-scale integration process that will revolutionize life science research, drug discovery and development, medical diagnostics and biotechnology. The ongoing miniaturization and large-scale i ...

Industries : Electronic Component and Semiconductor, Biotechnology

Stem Cell Technology: Current Applications and Future Directions

$ 4 850
July 2008

Analyzes adult and embryonic stem cell technology, applications (current and future), as well as the impact of stem cell focused products and services on healthcare markets and beyond. Provides quantitative market forecasts for near term applications and documents trends that impact product demand. ...

Industries : Biotechnology

Membrane Bioreactors: Global Markets

$ 4 850
June 2008

Analyzes the membrane and biological components of Membrane Bioreactors Examines system configurations and typical MBR performance Analyzes cost and system applications Examines companies active in the market, market share, and industry structure Provides quantitative evaluations for the major marke ...

Industries : Biotechnology, Nanotechnology

24/7 Customer Service

Contact Shadi now !

(866) 682 9815
Ask Shadi by email

Related industries

Biotechnology Industry

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.